Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance

The aim of this study was to improve the understanding of the pharmacokinetic-pharmacodynamic relationships of fosfomycin against extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli strains that have different fosfomycin MICs. Our methods included the use of a hollow fiber infection m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Docobo-Pérez, F., Drusano, G. L., Johnson, A., Goodwin, J., Whalley, S., Ramos-Martín, V., Ballestero-Tellez, M., Rodriguez-Martinez, J. M., Conejo, M. C., van Guilder, M., Rodríguez-Baño, J., Pascual, A., Hope, W. W.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2015
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4538498/
https://ncbi.nlm.nih.gov/pubmed/26124169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00752-15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars